Class Action Filed Against Cardlytics, Inc. (CDLX) - March 25, 2025 Deadline to Join - Contact Levi & Korsinsky

1. Cardlytics faces a class action lawsuit over securities fraud allegations. 2. The lawsuit claims misleading statements about revenue growth and consumer engagement risks. 3. Investors can seek compensation without out-of-pocket costs until March 25, 2025. 4. Allegations may impact investor confidence and stock price for CDLX. 5. Levi & Korsinsky has a strong track record in securities litigation.

Legal

70

4m saved

Insight

Article

FAQ

Why Bearish?

The lawsuit can undermine investor confidence, leading to a potential decline in stock price. Similar past cases have resulted in significant stock drops for affected companies.

How important is it?

Class action lawsuits significantly impact stock performance, particularly for small-cap firms like CDLX. The relevance stems from its implications for current and potential investors.

Why Short Term?

Initial market reactions to lawsuits typically occur within days to weeks. Long-term effects depend on lawsuit outcomes and company performance.

Related Companies

CDLX

NEW YORK, Jan. 31, 2025

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) of a class action securities lawsuit.

CLASS DEFINITION:

The lawsuit seeks to recover losses on behalf of Cardlytics investors who were adversely affected by alleged securities fraud between March 14, 2024 and August 7, 2024. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=126036&wire=4

CDLX investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS:

The filed complaint alleges that defendants made false statements and/or concealed that: (1) increasing consumer engagement led to an increase in consumer incentives; (2) the Company could not increase its billings commensurate with the increased consumer engagement; (3) as a result, there was a significant risk that its revenue growth would slow or decline; (4) the changes to Ads Decision Engine, which led to increased consumer engagement, led to the "under-delivery" of budgets and customers billing estimates; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

WHAT'S NEXT?

If you suffered a loss in Cardlytics during the relevant time frame, you have until March 25, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU:

If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY:

Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP